These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16252790)

  • 1. Subjective experience of recovery from schizophrenia-related disorders and atypical antipsychotics.
    Jenkins JH; Strauss ME; Carpenter EA; Miller D; Floersch J; Sajatovic M
    Int J Soc Psychiatry; 2005 Sep; 51(3):211-27. PubMed ID: 16252790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new paradigm of recovery from schizophrenia: cultural conundrums of improvement without cure.
    Jenkins JH; Carpenter-Song E
    Cult Med Psychiatry; 2005 Dec; 29(4):379-413. PubMed ID: 16773457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equipercentile linking of the BPRS and the PANSS.
    Leucht S; Rothe P; Davis JM; Engel RR
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):956-9. PubMed ID: 23433639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the utility of atypical antipsychotic medication in adults with mild mental retardation and comorbid psychiatric disorders.
    Shedlack KJ; Hennen J; Magee C; Cheron DM
    J Clin Psychiatry; 2005 Jan; 66(1):52-62. PubMed ID: 15669889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness of stigma among persons with schizophrenia: marking the contexts of lived experience.
    Jenkins JH; Carpenter-Song EA
    J Nerv Ment Dis; 2009 Jul; 197(7):520-9. PubMed ID: 19597360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
    Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M;
    Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of novel and conventional antipsychotic medication on subjective quality of life.
    Tempier R; Pawliuk N
    J Psychiatry Neurosci; 2001 Mar; 26(2):131-6. PubMed ID: 11291530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quest for well-being: a qualitative study of the experience of taking antipsychotic medication.
    Carrick R; Mitchell A; Powell RA; Lloyd K
    Psychol Psychother; 2004 Mar; 77(Pt 1):19-33. PubMed ID: 15025902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
    Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
    Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
    Schennach-Wolff R; Jäger M; Obermeier M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ; Riedel M
    World J Biol Psychiatry; 2010 Aug; 11(5):729-38. PubMed ID: 20380620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics side effects' influence on stigma of mental illness: focus group study results.
    Novak L; Svab V
    Psychiatr Danub; 2009 Mar; 21(1):99-102. PubMed ID: 19270631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between subjective well-being and pharmacological therapy in patients with psychotic disorders].
    Antonini V; Corradi A; Buizza C; Vittorielli M; Pioli R; Rossi G
    Recenti Prog Med; 2004 Dec; 95(12):581-4. PubMed ID: 15666490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation between objective and subjective domains of recovery among persons with schizophrenia-related disorders.
    Roe D; Mashiach-Eizenberg M; Lysaker PH
    Schizophr Res; 2011 Sep; 131(1-3):133-8. PubMed ID: 21669512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subjective view of positive symptoms and quality of life in patients with schizophrenia].
    Karow A; Schäfer I; Hirdes F; Osterwald C; Naber D
    Psychiatr Prax; 2008 Sep; 35(6):286-93. PubMed ID: 18504688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early improvement on antipsychotic treatment as a predictor of subsequent response in schizophrenia: analyses from ziprasidone clinical studies.
    O'Gorman C; Kapur S; Kolluri S; Kane J
    Hum Psychopharmacol; 2011; 26(4-5):282-90. PubMed ID: 21638329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of concordance between subjective improvement and symptom change in psychotic episodes.
    Kupper Z; Tschacher W
    Br J Clin Psychol; 2008 Mar; 47(Pt 1):75-93. PubMed ID: 17927846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics.
    Schimmelmann BG; Paulus S; Schacht M; Tilgner C; Schulte-Markwort M; Lambert M
    J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):249-58. PubMed ID: 15910209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.